Depression by morphine-6-glucuronide of nociceptive activity in rat thalamus neurons: comparison with morphine

Brain Research

Volumn 722, Issue 1-2, 1996, Pages 132-138

  Jurna, Ilmar ^a   Baldauf, Joseph ^a   Fleischer, Wolfgang ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b MUNDIPHARMA GMBH   (Germany)

Author keywords

analgesia; intrathecal; intravenous; morphine; morphine 6 glucuronide; thalamus neuron

Indexed keywords

MORPHINE; MORPHINE 6 GLUCURONIDE; NALOXONE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS;

EID: 0029975590     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00205-3     Document Type: Article

References (51)

1. Abbot, F.V. and Palmour, R.M., Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats, Life Sci., 43 (1988) 1685-1695.
2. Barton, C., Basbaum, A.I. and Fields, H.L., Dissociation of supraspinal and spinal actions of morphine: a quantitative evaluation, Brain Res., 188 (1980) 487-498.
3. Benoist, J.M., Kayser, V., Gautron, M. and Guilbaud, G., Low doses of morphine strongly depresses responses of specific nociceptive neurones in the ventrobasal complex of the rat, Pain, 15 (1983) 333-344.
4. Calvillo, O., Henry, J.L. and Neuman, R.S., Effects of morphine and naloxone on dorsal horn neurones in the cat, Can. J. Physiol. Pharmacol., 52 (1974) 1207-1211.
5. Carlsson, K.-H., Monzel, W. and Jurna, I., Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents, Pain, 32 (1988) 313-326.
6. Carrupt, P.-A., Testa, B., Bechalany, A., El Tayar, N., Descas, P. and Perrissoud, D., Morphine-6-glucuronide and morphine-3-glucuronide as molecular chameleons with unexpected lipophilicity, J. Med. Chem., 34 (1991) 1272-1275.
7. Casparis, P., Su alcuni derivati della morfina e loro azione analgesica, Boll. Chim. Farm., 89 (1950) 309-318.
8. Chen, Z.R., Irvine, R.J., Somogyi, A.A. and Bochner, F., Mu receptor binding of some commonly used opioides and their metabolites, Life Sci., 48 (1991) 2165-2171.
9. Christensen, C.B. and Jorgensen, L.N., Morphine-6-glucuronide has high affinity for the opioid receptor, Pharmacol. Toxicol., 60 (1987) 75-76.
10. Dewey, W.L., Snyder, J.W., Harris, L.S. and Howes, J.F., The effect of narcotics and narcotic antagonists on the tail-flick response in spinal mice, J. Pharm. Pharmacol., 21 (1969) 548-550.
11. Don, H.F., Dieppa, R.A. and Taylor, P., Narcotic analgesics in anuric patients, Anesthesiology, 42 (1975) 745-747.
12. Duggan, A.W., Hall, J.G. and Headley, P.M., Suppression of transmission of nociceptive impulses by morphine: selective effects of morphine administered in the region of the substantia gelatinosa. Br. J. Pharmacol., 61 (1977) 65-76.
13. Einarson, L., On the theory of gallocyanin-chromalum staining and its application for quantitative estimation of basophilia: a selective staining of exquisite progressivity, Acta Pathol. Microbiol. Scand., 28 (1951) 82-102.
14. Francés, B., Gout, R., Campistron, G. Pancon, E. and Cros, J., Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine, Progr. Clin. Biol. Res., 328 (1990) 477-480.
15. Glare, P.A. and Walsh, T.D., Clinical pharmacokinetics of morphine, Ther. Drug Monit., 13 (1991) 1-23.
16. Gong, Q.-L., Hedner, J., Björkman, R. and Hedner, T., Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat, Pain, 48 (1992) 249-255.
17. Hand, C.W., Blunnie, W.P., Claffey, L.P., McShane, A.J., McQuay, H.J. and Moore, R.A., Potential analgesic contribution from morphine-6-glucuronide in CSF, Lancet, II (1987) 1207-1208.
18. Hanna, M.H., Peat, S.J., Woodham, A., Knibb, A. and Fung, C., Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine, Br. J. Anaesth., 64 (1990) 547-550.
19. Irwin, S., Houde, R.W., Bennett, D.R., Hendershot, L.C. and Seevers, M.H., The effect of morphine, methadone and meperidine on some reflex responses of some spinal animals to nociceptive stimulation, J. Pharmacol. Exp. Ther., 101 (1951) 132-143.
20. Jurna, I., Dämpfung repetitiver Aktivierungsvorgänge an der spinalen Motorik durch Morphin. In R. Janzen, W.D. Keidel, A. Herz and C. Steichele (Eds.), Schmerz, Grundlagen, Pharmakologie, Therapie, Georg Thieme Verlag, Stuttgart, 1972, pp. 267-269.
21. Jurna, I. and Grossmann, W., The effect of morphine on the activity evoked in ventrolateral tract axons of the cat spinal cord, Exp. Brain Res., 24 (1976) 473-484.
22. Jurna, I. and Heinz, G., Differential effects of morphine and opioid analgesics on A and C fibre-evoked activity in ascending axons of the rat spinal cord, Brain Res., 171 (1979) 573-576.
23. Jurna, I., Spohrer, B. and Bock, R., Intrathecal injection of acetylsalicylic acid, salicylic acid and indometacin depresses C fibre-evoked activity in the rat thalamus and spinal cord, Pain, 49 (1992) 249-256.
24. Kitahata, L.M., Kosaka, Y., Taub, A., Bonikos, K and Hoffert, M., Lamina-specific suppression of dorsal-horn unit activity by morphine sulfate, Anesthesiology, 41 (1974) 39-48.
25. Laizure, S.C., Miller, J.H., Stevens, R.C., Donahue. D.J., Laster, R.E. and Brown, D., The disposition and cerebrospinal fluid penetration of morphine and its two major glucuronided metabolites in adults undergoing lumbar myelogram, Pharmacotherapy, 13 (1993) 471-475.
26. LeBars, D., Menétrey, D., Conseiller, C. and Besson, J.M., Depressive effects of morphine upon lamina V cells activities in the dorsal horn of the spinal cat. Brain Res., 98 (1975) 261-277.
27. LeBars, D., Guilbaud, G., Jurna, I. and Besson, J.M., Differential effects of morphine on responses of dorsal horn lamina V type cells elicited by A and C fibre stimulation in the spinal cat, Brain Res., 115 (1976) 518-524.
28. Lipkowski, A.W., Carr, D.B., Langlade, A., Osgood, P.F. and Szyfelbein, S.J., Morphine-3-glucuronide: silent regulator of morphine actions, Life Sci., 55 (1994) 149-154.
29. Mc Quay, H.J., Moore, R.A., Hand, C.W. and Sear, J.W., Potency of oral morphine, Lancet, II (1987) 1458-1459.
30. Osborne, R.J., Joel, S.P. and Slevin, M.L., Morphine intoxication in renal failure: the role of morphine-6-glucuronide, Br. Med. J., 292 (1986) 1548-1549.
31. Osborne, R., Joel, S., Trew, D. and Slevin, M., Analgesic activity of morphine-6-glucuronide, Lancet, I (1988) 828.
32. Osborne, R., Joel, S., Trew, D. and Slevin, M., Morphine and metabolite behaviour after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide, Clin. Pharmacol. Ther., 47 (1990) 12-19.
33. Pasternak, G.W., Bodnar, R.J., Clark, J.A. and Inturrisi, C.E., Morphine-6-glucuronide, a potent mu agonist, Life Sci., 41 (1987) 2845-2849.
34. Paul, D., Standifer, K.M., Inturrisi, C.E. and Pasternak, G.W., Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite, J. Pharmacol. Exp. Ther., 251 (1989) 477-483.
35. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, 1986.
36. Peterson, G.M., Randall, C.T.C. and Paterson, J., Plasma levels of morphine and morphine glucuronides in the treatment of cancer apin: relationship to renal function and route of administration, Eur. J. Clin. Pharmacol., 38 (1990) 121-124.
37. Regnard, C.F.B. and Twycross, R.G., Metabolism of narcotics, Br. Med. J., 288 (1984) 860.
38. Säwe, J. and Odar-Cederlöf, I., Kinetics of morphine in patients with renal failure, Eur. J. Clin. Pharmacol., 32 (1987) 377-382.
39. Säwe, J., Svensson, J.O. and Odar-Cederlöf, I., Kinetics of morphine in patients with renal failure, Lancet, II (1985) 211.
40. Samuelsson, H., Hedner, T., Venn, R. and Michalkiewicz, A., CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine. Pain, 52 (1993) 179-185.
41. Sear, J.W., Hand. C.W., Moore, R.A. and McQuay, H.J., Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites, Br. J. Anaesth., 62 (1989) 28-32.
42. Shimomura, K., Kamata, O., Ueki, S., Ida, S., Oguri, K., Yoshimura, H. and Tsukamoto, H., Analgesic effect of morphine glucuronides, Tohoku J. Exp. Med., 105 (1971) 45-52.
43. Smith, M.T., Watt, J.A. and Cramond, T., Morphine-3-glucuronide - a potent antagonist of morphine analgesia, Life Sci., 47 (1990) 579-585.
44. Sullivan, A.F., McQuay, H.J., Bailey, D. and Dickenson, A.H., The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat, Brain Res., 482 (1989) 219-224.
45. Toyooka, H., Kitahata, L.M., Dohi, S., Ohtani, M., Hanaoka, K. and Taub, A., Effects of morphine on the rexed lamina. VII. Spinal neuronal responses to graded noxious radiant heat stimulation, Exp. Neurol., 62 (1978) 146-158.
46. Van Dongen, R.T.M., Crul, B.J.P., Koopman-Kimenai, P.M. and Vree, T.B., Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine, Br. J. Clin. Pharmacol., 38 (1994) 271-273.
47. Wahlström, A., Winblad, B., Bixo, M. and Rane, A., Human brain metabolism of morphine and naloxone, Pain, 35 (1988) 121-127.
48. Wolff, T., Samuelsson, H. and Hedner, T., Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer patients after slow-release oral morphine administration, Pain, 62 (1995) 147-154.
49. Yaksh, T.L. and Rudy, T.A., Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques, Pain, 4 (1978) 299-359.
50. Yeung, J.C. and Rudy, T.A., Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine, J. Pharmacol. Exp. Ther., 215 (1980) 633-642.
51. Yoshimura, H., Ida, S., Oguri, K. and Tsukamoto, H., Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats, Biochem. Pharmacol., 22 (1973) 1423-1430.